Related Experiment Video
Updated: Jul 5, 2026

Using Retinal Imaging to Study Dementia
Published on: November 6, 2017
Imaging of mild cognitive impairment and early dementia
1University of California, Center for Imaging of Neurodegenerative Diseases Veterans Affairs Medical Center, San Francisco, California, USA. norbert.schuff@ucsf.edu
Abstract:
The concept of mild cognitive impairment (MCI) has been introduced to describe older individuals who cognitively lie between normal ageing and dementia. Nowadays, there is a particular interest in MCI because this syndrome is thought to be a transitional stage to Alzheimer's disease (AD) that may define a window for effective therapeutic interventions. However, not all patients with MCI will go on to develop AD. Imaging offers an extraordinary opportunity to study MCI. We will review key findings of brain imaging studies in MCI, including structural brain changes studied with MRI, white matter changes with diffusion tensor imaging and altered brain activity and blood flow studied with various imaging modalities, such as positron emission tomography, single-photon emission computed tomography and arterial spin labelling MRI, a non-invasive approach to measure cerebral blood flow. The strength and limitations of each modality for diagnosis of MCI, prediction of MCI outcome and assessment of drug efficacy will be discussed.
Insights
Mild cognitive impairment (MCI) bridges normal aging and dementia, potentially indicating early Alzheimer's disease (AD). Brain imaging techniques like MRI and PET offer insights into MCI progression and therapeutic possibilities.
Area of Science:
- Neurology
- Radiology
- Gerontology
Background:
- Mild cognitive impairment (MCI) is a transitional stage between normal aging and dementia.
- MCI is of significant interest as a potential prodromal phase of Alzheimer's disease (AD).
- Not all individuals with MCI progress to AD, highlighting the need for accurate diagnostic and prognostic tools.
Purpose of the Study:
- To review key findings from brain imaging studies in MCI.
- To discuss the utility of various imaging modalities for MCI diagnosis, outcome prediction, and therapeutic assessment.
- To explore the potential of imaging as a window for effective therapeutic interventions in MCI.
Main Methods:
- Review of structural brain changes using Magnetic Resonance Imaging (MRI).
- Assessment of white matter integrity using Diffusion Tensor Imaging (DTI).
- Evaluation of altered brain activity and blood flow using Positron Emission Tomography (PET), Single-Photon Emission Computed Tomography (SPECT), and Arterial Spin Labelling MRI (ASL-MRI).
Main Results:
- Structural MRI reveals brain changes associated with MCI.
- DTI demonstrates white matter alterations in individuals with MCI.
- PET, SPECT, and ASL-MRI show altered brain activity and perfusion in MCI, offering insights into disease mechanisms.
Conclusions:
- Brain imaging provides valuable insights into the pathophysiology of MCI.
- Different imaging modalities have unique strengths and limitations for MCI diagnosis and prognosis.
- Imaging plays a crucial role in identifying therapeutic targets and assessing treatment efficacy in MCI.
Related Concept Videos
Dementia l: Introduction
Dementia
The progression of dementia is generally gradual.
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease l: Introduction
Imaging Studies I: CT and MRI
Description of the Procedures
Computed Tomography (CT) scan:
Computed Tomography (CT) scans use X-ray technology to generate detailed images of bones, organs, and tissues. During the scan, the patient lies on a moving table...
Imaging Studies II: Positron Emission Tomography and Scintigraphy
Fundamental Principles of PET
